Skip to main content
OpenTrials
Completed

NCT Number: NCT04267874

Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

55 year–77 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

PRIMARY FEASIBILITY OBJECTIVE:

I. To evaluate the feasibility of establishing a diet intervention trial with longitudinal microbiome collection in Ohio State University Comprehensive Cancer Center (OSUCCC) Lung Cancer Screening Clinic (OSUCCC-LCSC).

PRIMARY SCIENTIFIC OBJECTIVE:

I. To determine the impact of the black raspberry (BRB) nectar intervention on the microbiome and inflammatory biomarkers.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive BRB nectar orally (PO) twice daily (BID) for weeks 0-4 and then receive placebo PO BID for weeks 6-10 in the absence of unacceptable toxicity. Patients also undergo collection of nasal swabs, blood, urine, and stool samples at weeks 0, 4, 6, and 10.

ARM II: Patients receive placebo PO BID for weeks 0-4 and then receive BRB nectar PO BID for weeks 6-10 in the absence of unacceptable toxicity. Patients also undergo collection of nasal swabs, blood, urine, and stool samples at weeks 0, 4, 6, and 10.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a 30 pack-year smoking history
  • Be either a current smoker or a former smoker that quit in the last 15 years. Any individual who is currently smoking and has smoked more than 100 cigarettes in their lifetime will be identified as a current smoker
  • Agree to consume a standardized vitamin / mineral supplement and avoid other nutritional, dietary or alternative medications / supplements / probiotics for the duration of the study
  • Agree to follow a berry-free / controlled phenolic diet and to document consumption of polyphenolic foods each day of the study using a simple daily form

Exclusion criteria

  • Person has an allergy to any berries, pectin, or food colorants apples,as well as kiwi fruit, strawberries, soy sauce, pine nuts, almonds, cherries, peaches, blackberries, pears
  • Person states that they are not a:
  • Current smoker: active cigarette smoker who has smoked more than 30 pack-years in the last 15 years OR
  • Former smoker: not a current smoker active cigarette smoker who has smoked more than 30 pack years in the last 15 years
  • Person is unwilling to follow a berry-free/controlled polyphenol diet while on study
  • Person has history of metabolic disorders (diabetes, hyper/hypo-thyroidism, etc.); digestive illness which may result in nutrient malabsorption (Crohn's disease, Celiac, renal/hepatic insufficiency, short bowel, etc.); disorders that affect connective tissues; or blood clotting disorders
  • Person has allergy or food intolerance to ingredients in study products (black raspberries or other berries)
  • Person is on a regimen of any of the following medications:
  • Immunosuppressants, bisphosphonates, or steroids.
  • Anticoagulants (warfarin, apixaban, dabigatran, and rivaroxaban)
  • Probiotics
  • Person is undergoing treatment for cancer in any form
  • Person is currently pregnant or nursing or plans to become pregnant during this study
  • Person plans to enter smoking cessation or change their smoking status during the course of the study

Treatment and study plan

Biospecimen Collection

Procedure

Undergo collection of nasal swabs, blood, urine, and stool

Nutritional supplementation

Dietary Supplement

Given black raspberry nectar PO

Other names: supplementation

Placebo Administration

Drug

Given PO

Questionnaire Administration

Other

Ancillary studies

Primary outcomes

  1. Recruitment rates

    Time frame: Up to 3 years

    Recruitment rates will be defined as the proportion of screened accrued relative to those approached. Successful recruitment rates will be defined as >= 10% of participants approached agree to participate.

  2. Study adherence

    Time frame: Up to 3 years

    Study adherence will be defined as the percent of the biospecimens collected at the end of the study period, with a compliance goal of 60%. Will track the monthly collection of data and document reasons for missing any scheduled collection dates. The proportions of missing information at each time point will be calculated. Descriptive statistics will examine the distribution of all patient and treatment characteristics, overall and by patient and disease characteristics.

  3. Inflammatory markers found in nasal brushings

    Time frame: Up to 3 years

    Evaluated by ribonucleic acid sequencing.

  4. Changes in stool microbe relative abundances

    Time frame: Up to 3 years

    Evaluated by metagenomic whole sequencing.

  5. Biologic responses to the black raspberry (BRB) nectar

    Time frame: Up to 3 years

    Samples of urine, stool. and blood will be analyzed for BRB phytochemicals (ellagitannins, ellagic acid, quercetin glycosides, anthocyanins) and their metabolites (urolithins, quercetin glucuronides/sulfates, methylated anthocyanins).

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

The BE WELL Study: Black Raspberry Beverage Working to Prevent Lung Cancer

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Feb 13, 2020
Registry last updated
Dec 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.